We studied the effects of native (N) and oxidized (Ox) low density lipoproteins (LDLs) on adenosine 3',5'-cyclic monophosphate (cAMP)-mediated and on guanosine 3',5'-cyclic monophosphate (cGMP) -mediated dilator mechanisms in isolated, perfused human mammary and rabbit femoral arteries. Dilations were induced in preconstricted, deendothelialized segments by either forskolin (Fo) or sodium nitroprusside (SNP) (intraluminal or adventitial application). Lipoproteins (0.5 mg/ml) were administered to the segments from the intraluminal side. N-LDL had no effect on Fo-induced dilation and caused a weak attenuation of SNP-induced dilation only when SNP was also administered into the intraluminal perfusate. In contrast, Ox-LDL inhibited both Fo-and SNP-induced dilation, independent of the route of dilator application. The effects of Ox-LDL were specific for dilation mediated by cyclic nucleotides. Dilation elicited by the Ca 2+ antagonist nitrendipine was inhibited neither by N-LDL nor by Ox-LDL. Determination of basal and stimulated (SNP, Fo) cGMP and cAMP content in rabbit femoral segments after preincubatlon with N-LDL and Ox-LDL revealed a significant decrease of stimulated vascular cGMP and cAMP content by Ox-LDL, whereas N-LDL had no effect. These data indicate that Ox-LDL selectively inhibits vascular smooth muscle relaxation elicited by increases in cyclic nucleotides. This inhibition might contribute to the attenuation of vasodilation in hypercholesterolemia and atherosclerosis. (Arteriosclerosis and Thrombosis 1992;12:180-186)
D
uring the development of arteriosclerosis, changes in vascular reactivity, particularly the attenuation of dilator responses, 1 -6 have been observed. The heterogeneity of these changes implies the involvement of different underlying mechanisms. Impairment of endothelium-mediated dilation is frequently associated with early stages of the disease, 2 -4 whereas attenuation of dilation to endothelium-independent agonists has been observed in more advanced stages.
2 -7 - 8 The latter attenuation of vasodilation suggests that dilator mechanisms distal to the level of the endothelium are disturbed. This could involve either impaired diffusion of exogenously applied agonists or endotheliumderived dilators to the vascular smooth muscle or impairment of the smooth muscle itself.
Because native (N) and oxidized (Ox) low density lipoproteins (LDLs) accumulate in the arterial - 11 they could interfere with the dilator mechanisms of endothelium-derived autacoids such as nitric oxide (NO) or prostacyclin at the level of the vascular smooth muscle. Both dilators act via increases in cyclic nucleotides: NO-induced dilation involves guanosine 3',5'-cyclic monophosphate (cGMP), whereas prostacyclin is mediated by adenosine 3',5'-cyclic monophosphate (cAMP). 12 - 13 To analyze the possible influence of lipoproteins on cyclic nucleotide-mediated dilator mechanisms, we studied the effects of N-LDL and Ox-LDL on cGMP and cAMP content and of dilator responses induced by cyclic nucleotide-increasing agonists in isolated rabbit and human arteries. Forskolin (Fo) was used as a stimulus for adenylate cyclase and sodium nitroprusside (SNP) as a stimulus for guanylate cyclase.
heim, FRG) were added to avoid autoxidation, proteolytic digestion, and bacterial growth.
14 LDLs (density, 1.019-1.063 g/ral) were isolated by sequential ultracentrifugation at 200,000g (modified from the method used by Havel et al 15 to minimize preparation time). Thereafter, LDLs were concentrated by centrifugal ultrafiltration and desalted by gel filtration with a Sephadex G-75-120 column (Sigma). The column was equilibrated with Tyrode's solution containing EDTA (0.2 mM) and BHT (20 fiM). Stock solutions of LDL (8-12 mg protein/ml) were sterilized by filtration (Millex, Millipore, FRG; pore size, 0.22 /xm) and kept in the dark at 4°C for no longer than 3 weeks. LDLs prepared by this method are referred to as native LDL (N-LDL). Protein content was measured as described by Bradford. 16 LDL homogeneity was tested by agarose gel electrophoresis (lipidophor electrophoresis kits from IMMUNO GmbH, Heidelberg, FRG), during which the LDL preparation migrated as a single, sharp band corresponding to the apolipoprotein B-100 fraction. In total, six different LDL preparations were used in this study.
For oxidative modification, N-LDLs were separated from EDTA and BHT by gel filtration on a Sephadex G 75-120 column equilibrated with 0.02 M NaH 2 PO 4 buffer (pH 7.4). Antioxidant-free LDLs (0.3 mg protein/ml) were incubated with CuSO 4 (5 /xM) for 20-24 hours at 23°C. The degree of oxidation was quantified by three different methods: 1) the absorption increase at the 234-nm wavelength, indicating conjugated diene formation of fatty acids 17 ; 2) the increase in relative mobility on agarose gel, indicating an enhanced negative charge on Ox-LDL
18
; and 3) sodium dodecyl sulfate-polyacrylamide gel electrophoresis, which demonstrated fractionation of apolipoprotein B-100. 19 When the formation of conjugated dienes (as an index of lipid peroxidation 17 ) was about 80% of its maximum (Em,;,), the oxidative process was stopped by adding BHT (20 nM) and EDTA (02 mM) to the mixture. Therefore, we first determined in one sample of an LDL preparation the individual E^ and E^, of this preparation at 234 nm ( E^, absorption before adding Cu 2+ into the cuvette; E^,, maximal absorption value, reached approximately 24 hours after initiating the oxidation). From these values, the degree of LDL oxidation as a percentage of maximum absorbance was determined by measuring the absorbance of samples repeatedly during oxidation of the entire preparation. The relative mobility of Ox-LDL on agarose gel electrophoresis as an index of lipoprotein oxidation 18 was then 13 compared with that of N-LDL. Finally, OxLDLs were desalted, concentrated to the same volume as before starting the oxidation procedure, and stored in the same manner as N-LDL. 
Vessel Preparation
Intact segments of the femoral artery were obtained from rabbits of either sex (weight 2.5-3.5 kg). The segments were carefully cleaned from connective tissue, and the endothelium was removed mechanically by gently rubbing the segments over a rough steel canrtula. Absence of endothelium was proven by the lack of a dilator response to acetylcholine. 20 The segments were fixed between two steel cannulas and placed in an organ bath (37°C) containing oxygenated Tyrode's solution (pH 7.4). The solution was perfused through the organ bath at a rate of 0.66 rnl/min. In addition to superfusion in the organ bath, the segments were perfused intraluminally (Tyrode's solution: Po^, 130 mm Hg; PcOz, 28 mm Hg; pH 7.38; at a rate of 0.5 ml/min).
Side branches of human internal mammary arteries were obtained from patients undergoing internal mammary artery coronary bypass operations (Department of Thoracic and Cardiac Surgery, University Hospital of Freiburg, Freiburg, FRG). The human arteries were prepared in the same manner as described for the rabbit femoral arteries.
Outer vascular diameters were recorded continuously by a photoelectric device. The transmural pressure was adjusted hydrostatically to 40 mm Hg (isobaric conditions). Under these conditions, resting diameter of the femoral arteries was 1,657±27 jam (n=60), and of the human arteries 1,893±67 /xM (n=8). Full details of this experimental setup have been published earlier. 20 Vasodilation was induced by adding the respective agonist either to the organ bath (SNP, Fo, nitrendipine) or to the intraluminal perfusate (SNP) of norepinephrine-constricted segments. The level of preconstriction induced by norepinephrine (0.01-0.1 /iM) amounted to 19 ±4% of resting diameter. Effects of the lipoproteins on dilation induced by SNP, Fo, and nitrendipine were studied by comparing dilation before and after preincubation of the segments with N-LDL or Ox-LDL (0.5 mg/ml for 30 minutes added to the intraluminal perfusate). During determination of the dilator responses, the segments were continuously perfused intraluminally with the lipoproteins. To exclude a time-related impairment of dilation, a sec- ond segment obtained from the same animal without lipoprotein incubation served in each experiment as the control. Dilator responses of these control segments did not change during the experiments. Because Ox-LDL has an enhancing effect on norepinephrine-induced vasoconstrictions, 19 the norepinephrine concentration in the organ bath was lowered, in the presence of Ox-LDL, to achieve the same level of preconstriction as under control conditions without Ox-LDL.
Determination of cGMP and cAMP
Endothelium-denuded rabbit femoral segments were equilibrated for 30 minutes in Tyrode's solution. Subsequently, they were placed into individual test tubes. For assessing the effect of N-LDL or Ox-LDL on cyclic nucleotide formation, they were preincubated for 30 minutes with 0.5 mg/ml of the lipoproteins or with an aliquot of the respective buffer as control and then stimulated with 1 uM SNP or 1 ^xn Fo for 60 seconds. To prevent catabolism of the cyclic nucleotides formed, the incubation was performed in the presence of the phosphodiesterase inhibitors (100 uM) zaprinast (to inhibit cGMP degradation) or EBMX (to inhibit cAMP degradation). 21 The incubation was stopped by freezing the segments with a precooled (liquid nitrogen) clamp. Segments were homogenized in 6% trichloroacetic acid, and after low-speed centrifugation, the supernatants were ether-extracted and quantified by radioimmunoassay for their cyclic cGMP or cAMP content, respectively. The amount of cyclic nucleotides is expressed in picomoles cyclic nucleotides per milligram protein of the sample (determined by the method of Lowry et al 22 ) .
Statistics
All data are presented as mean±SEM. Dilator responses are expressed as percentages of the Initial steady-state constriction induced by norepinephrine. Differences were tested with Student's t test for paired data. Differences were considered significant at an error probability of/J^0.05.
Results

Effects of Native and Oxidized Low Density Lipoproteins on cGMP-Mediated Vasodilation Induced by Sodium Nitroprusside
After preincubation of deendothelialized segments with N-LDL (added intraluminally), SNP-induced dilation remained unaffected when SNP was applied to the organ bath ( Figure 1, left panel) . However, when added together with N-LDL to the intraluminal perfusate, dilation was significantly reduced ( Figure  1, right panel) . Preincubation of the segments with Ox-LDL significantly inhibited SNP-induced dilation (Figure 2, left panel) . This inhibition tended to be more pronounced when SNP was added together with Ox-LDL to the intraluminal perfusate (Figure 2 , right panel).
Inhibition of the dilation by Ox-LDL and N-LDL was partly reversible 30 minutes after stopping the perfusion with Ox-LDL (data not shown). Ox-LDL inhibited SNP-induced dilation also in human internal mammary arteries ( Figure 3 , left panel; Ox-LDL and SNP added separately).
Inhibition of cAMP-Mediated Vasodilation by Native and Oxidized Low Density Lipoproteins
Fo-induced dilation of rabbit femoral segments was impaired only by Ox-LDL (Figure 4 , left panel) but not by N-LDL (Figure 4, right panel) . The mode of application of Fo (separate or combined with the lipoproteins) had no influence on the degree of inhibition. The inhibition was partly reversible 30 minutes after stopping the perfusion with Ox-LDL (data not shown). Fo-induced dilation also was inhibited by Ox-LDL in human internal mammary arteries ( Figure 3, right panel) .
Influence of Native and Oxidized Low Density Lipoproteins on Vascular Content of cGMP andcAMP
To investigate whether inhibition of the mechanical responses by the lipoproteins was associated with 
Influence of Oxidized Low Density Lipoproteins on Dilation Induced by Nitrendipine
To clarify whether inhibition of dilation by lipoproteins was a general phenomenon or specific for cyclic nucleotides, we studied the influence of N-LDL and Ox-LDL on dilation induced by the Ca 2+ antagonist nitrendipine. Preincubation of preconstricted femoral segments with Ox-LDL (0.5 mg/ml, for 30 minutes) had no influence on dilation elicited by 0.03 and 0.3 uM nitrendipine ( Figure 6 ). N-LDL was also without effect (data not shown).
Discussion
The data presented in this study demonstrate that Ox-LDLs inhibit vasodilation mediated by cyclic nucleotides in isolated rabbit and human arteries. The inhibition of dilator responses was accompanied by an attenuation of the agonist-induced rise in tissue content of the cyclic nucleotides cAMP and cGMP. Dilation induced by the Ca 2+ antagonist nitrendipine remained unaffected. N-LDL only caused a weak inhibition of SNP-induced dilation when the former could interact directly with this nitrovasodilator. These findings may provide additional understanding of the mechanisms responsible for the frequently described attenuation of dilation in atherosclerotic arteries, late. 9 -11 In addition to direct effects on the endothelium, the lipoproteins could decrease the efficacy of endogenous dilators and exogenously applied drugs either by direct inactivation of the dilators or by affecting the signal cascade in the smooth muscle cells. This study provides evidence for both mechanisms.
Inactivation by N-LDL or Ox-LDL may be the predominant mechanism for the attenuated effects of dilators that are identical with NO (endotheliumderived relaxing factor [EDRF]) 23 or that release NO (SNP). 24 When SNP was applied together with the lipoproteins from the intraluminal side, dilation was inhibited to a greater extent compared with separate application of lipoproteins and the drug. This observation argues in favor of an interaction between the lipoproteins and the NO-releasing SNP. It is also in agreement with a previous study, in which direct inactivation of EDRF/NO by N-LDL and Ox-LDL was demonstrated. 25 The higher degree of inhibition of dilation and rise in cGMP caused by Ox-LDL compared with N-LDL may result from a higher capacity of Ox-LDL to inactivate SNP or NO, respectively. Furthermore, Ox-LDL might interfere with the cGMP-forming enzyme guanylate cyclase. Inhibition of an isolated soluble guanylate cyclase by Ox-LDL has been demonstrated in vitro (Reference 26 and our own unpublished observations) and may also take place intracellularly. Yet, the lack of effect of Ox-LDL on basal levels of cGMP in this study makes this possibility less likely. The mode of application of Fo (separately or combined with the lipoproteins), however, had no influence on the degree of inhibition of vasodilation. A mechanism different from inactivation of the vasodilator by Ox-LDL may be responsible for the inhibition of Fo-induced dilation and rise in cAMP levels. Direct inactivation of the enzyme adenylate cyclase may play a minor role because -as in the case of guanylate cyclase -the basal vascular content of cAMP was not affected by Ox-LDL. Thus, the specific site of action of Ox-LDL 
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on the attenuation of Fo-induced relaxation cannot be identified by the experiments in this study. One might speculate, however, that Ox-LDL affects the signal chain linking Fo to the membrane-bound adenylate cyclase by changing the fluidity of the cell membrane through excess cholesterol load. 27 Because it is known that Ox-LDL may exert cytotoxic effects, 28 - 30 we considered the possibility that Ox-LDL inhibited dilation by an unspecific attenuation of the dilator capability of isolated segments. However, two observations argue against this assumption: dilation induced by the Ca 2+ antagonist nitrendipine was not affected, and inhibition of the SNP-and Fo-induced dilation was partly reversible. Therefore, a cytotoxic effect of Ox-LDL after 30 minutes' incubation seems unlikely.
In several studies, an enhanced responsiveness of atherosclerotic arteries to vasoconstrictors has been reported. 31 " 33 Reduction of cGMP and cAMP levels, as described in this study, may also contribute to this phenomenon. A decreased level of tissue cyclic nucleotides could render arteries more sensitive to contractile agonists 34 - 35 and also could explain the potentiation of contractile responses by Ox-LDL in vitro. 19 However, in this study the unstimulated cAMP and cGMP levels were not affected after incubation of endothelium-denuded segments with N-LDL or Ox-LDL. Thus, decreased cyclic nucleotide levels in segments after incubation with Ox-LDL are unlikely to be the sole cause for potentiation of vasoconstrictors.
In summary, this study demonstrates attenuation of dilation mediated by cyclic nucleotides in human and rabbit arteries after incubation with LDLs. likely mechanisms are inactivation of NO by N-LDL or Ox-LDL and interference of Ox-LDL with the adenylate cyclase-stimulating cascade. These mechanisms may contribute to the reduced dilator responses observed in atherosclerotic arteries.
